simendan has been researched along with Cardio-Renal Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HT; Chen, CH; Chen, YL; Chiang, JY; Sung, PH; Yang, CC; Yip, HK | 1 |
| Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L | 1 |
| Andersson, B; Bartfay, SE; Bergh, N; Bollano, E; Dahlberg, P; Gilljam, T; Hjalmarsson, C; Karason, K; Lannemyr, L; Ljungman, C; Ricksten, SE; Rundqvist, B | 1 |
| Bouchez, S; Girardis, M; Guarracino, F; Herpain, A; Knotzer, J; Levy, B; Liebregts, T; Pollesello, P; Ricksten, SE; Riha, H; Rudiger, A; Sangalli, F | 1 |
| Brasolin, B; Bruno, N; Caira, C; D'Ambrosi, A; Fedele, F; Mancone, M | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Feola, M; Ferreri, C; Leto, L; Testa, M | 1 |
2 review(s) available for simendan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.
Topics: Animals; Cardio-Renal Syndrome; Cardiotonic Agents; Critical Care; Humans; Intensive Care Units; Recovery of Function; Risk Factors; Shock, Cardiogenic; Shock, Septic; Simendan; Treatment Outcome; Vasodilator Agents | 2019 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
2 trial(s) available for simendan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
Topics: Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamic Monitoring; Hemodynamics; Humans; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Renal Insufficiency; Renal Plasma Flow; Simendan | 2018 |
Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.
Topics: Aged; Cardio-Renal Syndrome; Double-Blind Method; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hydrazones; Kidney; Male; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents | 2014 |
3 other study(ies) available for simendan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.
Topics: Aminobutyrates; Animals; Apoptosis; Biphenyl Compounds; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Combinations; Fibrosis; Humans; Inflammation; Kidney; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Simendan; Stroke Volume; Valsartan; Ventricular Function, Left | 2022 |
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan | 2017 |
The worsening renal failure in a chronic cardio-renal syndrome type II: efficacy of a single levosimendan infusion.
Topics: Aged; Cardio-Renal Syndrome; Disease Progression; Humans; Hydrazones; Infusions, Intravenous; Male; Pyridazines; Renal Insufficiency; Simendan; Treatment Outcome; Vasodilator Agents | 2016 |